Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07468058

Diabetic Retinopathy Prevalence And Risk Factors

Diabetic Retinopathy Prevalence And Risk Factors From A Hospital - Based Cohort In Central Vietnam

Status
Recruiting
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Da Nang Family General Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this retrospective observational study is to evaluate the prevalence and severity of diabetic retinopathy (DR) and to identify associated risk factors among patients with diabetes mellitus at Gia Dinh Family Hospital in Da Nang, Vietnam. The main questions it aims to answer are: 1. What is the prevalence and distribution of different stages of diabetic retinopathy among diabetic patients at this hospital? 2. Which clinical and laboratory factors are associated with the presence of diabetic retinopathy?

Detailed description

Diabetic retinopathy (DR) is a leading cause of preventable visual impairment worldwide. Global estimates suggest that approximately 22-26% of people with diabetes have some degree of DR, with about 6% experiencing vision-threatening disease. The burden is expected to increase substantially, particularly in low- and middle-income countries. Vietnam is experiencing a rapid rise in diabetes prevalence, however, data from Central Vietnam, particularly from multidisciplinary general hospitals, remain limited. This study aims to evalutate the local prevalence, severity distribution, and associated risk factors of DR in a general hospital in Da Nang which is essential to inform screening strategies, optimize management, and reduce preventable vision loss.

Conditions

Interventions

TypeNameDescription
OTHERfundus examination and optical coherence tomography (OCT)Patients will be identified through the Ehealth program at the Family Hospital, Da Nang. All diabetic patients who visited the Center of Endocrinology and Diabetes and had ophthalmologic examination, including fundus examination and optical coherence tomography (OCT), during the study period will be screened for eligibility

Timeline

Start date
2025-11-25
Primary completion
2026-03-15
Completion
2026-03-30
First posted
2026-03-12
Last updated
2026-03-12

Locations

1 site across 1 country: Vietnam

Source: ClinicalTrials.gov record NCT07468058. Inclusion in this directory is not an endorsement.